The Sagility India IPO is open for subscription from November 5 to November 7, 2024. The IPO has a face value of ₹10 per share, with a price band set between ₹28 and ₹30 per share. Investors can apply in lots of 500 shares each, with a minimum application amount of ₹15,000 and a maximum of ₹1,95,000 for retail investors. The total issue size comprises 702,199,262 shares, aggregating to ₹2,106.60 crore, all of which are offered for sale. An employee discount of ₹2 per share is available for eligible employees.
Key dates for the IPO include the basis of allotment on November 8, 2024, followed by the initiation of refunds on the same day. Shares are expected to be credited to Demat accounts on November 11, 2024, and the listing date is set for November 12, 2024.
Originally established as Berkmeer India Pvt. Ltd in Bengaluru, Karnataka, in July 2021, the company underwent significant changes, including a rebranding to Sagility India Pvt. Ltd in September 2022. By May 2024, after converting to a public limited entity, it adopted its current name, Sagility India Ltd.
Sagility acquired the healthcare services segment of Hinduja Global Solutions in January 2022. This acquisition bolstered its position within the healthcare domain, where Hinduja Global Solutions had been a recognized provider of services to Payer clients since 2000. This expertise allowed Sagility to rapidly expand its scope within the healthcare industry, serving both U.S. health insurance companies (Payers) and providers, including hospitals, diagnostic centres, and medical device companies.
Solutions for Payers
Sagility India offers end-to-end healthcare solutions to U.S. Payers, supporting operations through centralized claims administration, clinical management, and payment integrity. These services aim to improve operational efficiency and enhance claims processing accuracy for health insurance clients.
Services for Providers
For Providers, Sagility delivers revenue cycle management services, which assist hospitals, physicians, and other medical entities in handling claims and billing. The company also provides certain payer services to pharmacy benefit managers (PBMs) who manage prescription drug benefits for insured members.
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.